Drug intelligence / Profile preview

xiaoer zhibao wan

Development stage: Unknown
Lead developer: Liaoning Jindan Pharmaceutical
Modality: Small Molecules
Administration: Oral

Overview

Xiaoer Zhibao Wan is a traditional Chinese medicine (TCM) product developed and manufactured by Liaoning Jindan Pharmaceutical. It is an approved pediatric medication formulated as a pill (Wan). The formula is traditionally used to treat symptoms associated with the common cold, influenza, and digestive upsets in children. Its primary indications include relieving fever, resolving phlegm, suppressing cough, and alleviating food stagnation (indigestion). In TCM theory, it functions by clearing heat, detoxifying, and calming fright. The preparation typically consists of a complex mixture of herbal and mineral ingredients, including Arisaema cum Bile, Coptis chinensis, and Scutellaria baicalensis.

Brand names: Xiaoer Zhibao Wan
Other names: 小儿至宝丸

Beyond the preview

Go deeper on xiaoer zhibao wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on xiaoer zhibao wan.

Explore the full profile